newscientist.com

First-of-kind Guillain-Barré drug switches off part of immune system | New Scientist

A treatment that turns off the bit of the immune system that goes haywire in Guillain-Barré syndrome may be the first targeted therapy approved for the autoimmune condition

This site doesn’t allow embedding inside another page — open it in a new tab. Your Weird rating still works from the top bar.

Open source